Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___	O
Chief	O
Complaint:	O
Lower	O
Extremity	O
Edema	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
with	O
history	O
of	O
severe	O
aortic	O
stenosis	O
(AS)	O
and	O
atrial	O
fibrillation	O
(on	O
metoprolol	O
and	O
warfarin)	O
admitted	O
with	O
several	O
weeks	O
of	O
progressive	O
bilateral	O
lower	O
extremity	O
edema.	O
Daughter,	O
who	O
was	O
at	O
the	O
bedside,	O
reported	O
the	O
patient	O
had	O
3	O
months	O
of	O
worsening	O
bilateral	O
lower	O
leg	O
swelling.	O
Patient	O
has	O
some	O
pedal	O
edema	O
at	O
baseline.	O
Daughter	O
took	O
patient	O
to	O
see	O
PCP	O
for	O
evaluation	O
of	O
her	O
___	O
and,	O
per	O
daughter,	O
PCP	O
was	O
concerned	O
that	O
the	O
AS	O
might	O
be	O
causing	O
this.	O
Patient	O
has	O
seen	O
cardiologist	O
Dr.	O
___	O
at	O
___	O
who	O
was	O
not	O
"worried"	O
about	O
her	O
AS	O
and	O
wanted	O
to	O
follow	O
up	O
yearly.	O
Last	O
visit	O
with	O
Dr.	O
___	O
was	O
"months	O
ago".	O
Patient	O
denied	O
dyspnea	O
on	O
exertion,	O
chest	O
pain,	O
shortness	O
of	O
breath,	O
presyncope	O
or	O
syncope.	O
Patient	O
stated	O
she	O
walks	O
with	O
a	O
cane	O
limited	O
distances,	O
rarely	O
leaves	O
the	O
house,	O
but	O
on	O
walking	O
from	O
her	O
bedroom	O
to	O
the	O
kitchen	O
daily	O
denies	O
shortness	O
of	O
breath,	O
presyncope	O
or	O
chest	O
pain.	O
She	O
was	O
surprised	O
to	O
be	O
hospitalized	O
and	O
has	O
not	O
been	O
bothered	O
by	O
her	O
___	O
edema.	O
She	O
feels	O
quite	O
well	O
and	O
feels	O
at	O
her	O
baseline.	O
Since	O
a	O
fall	O
a	O
few	O
years	O
ago,	O
patient	O
has	O
been	O
relatively	O
immobile.	O
In	O
the	O
ED,	O
labs	O
notable	O
for:	O
NT-Pro-BNP	O
1255,	O
troponin-T	O
<0.01,	O
Cr	O
1.0,	O
chemistries	O
wnl,	O
CBC	O
wnl,	O
INR	O
2.0.	O
Chest	O
X	O
ray	O
showed	O
no	O
focal	O
consolidation,	O
effusion,	O
or	O
pneumothorax.	O
The	O
cardiac	O
silhouette	O
size	O
was	O
top	O
normal.	O
Aorta	O
was	O
tortuous	O
with	O
atherosclerotic	O
calcifications	O
noted	O
at	O
the	O
arch.	O
Decision	O
was	O
made	O
to	O
admit	O
for	O
___	O
evaluation.	O
Vitals	O
prior	O
to	O
transfer:	O
T	O
97.7	O
HR	O
85	O
BP	O
185/106	O
RR	O
18	O
SaO2	O
100%	O
on	O
RA.	O
ROS:	O
Per	O
HPI	O
Past	O
Medical	O
History:	O
-Atrial	O
fibrillation	O
on	O
anti-coagulation	O
-Aortic	O
stenosis,	O
severe	O
-Macular	I-Visual_impairment
degeneration	B-Visual_impairment
-Prolapsed	O
uterus	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
family	O
history	O
of	O
premature	O
CVD.	O
Otherwise	O
non-contributory.	O
Physical	O
Exam:	O
On	O
admission	O
General:	O
Elderly	O
white	O
woman,	O
alert,	O
in	O
no	O
acute	O
distress.	O
VS:	O
T	O
97.5	O
BP	O
149/75	O
Pulse	O
99	O
RR	O
18	O
SaO2	O
96%	O
on	O
RA;	O
Weight	O
75.8	O
kg	O
HEENT:	O
Sclera	O
anicteric,	O
conjunctivae	O
noninjected,	O
neck	O
supple,	O
JVP	O
up	O
to	O
ear	O
lobe	O
at	O
45	O
degrees	O
CV:	O
irregularly	O
irregular,	O
___	O
harsh	O
systolic	O
murmur,	O
no	O
rubs	O
or	O
gallops	O
Lungs:	O
Clear	O
to	O
auscultation	O
bilaterally--no	O
wheezes,	O
rales,	O
rhonchi	O
Abdomen:	O
Soft,	O
non-tender,	O
non-distended	O
GU:	O
No	O
Foley	O
Ext:	O
Lower	O
extremities	O
edematous	O
with	O
skin	O
thickening,	O
with	O
~1+	O
pitting	O
component;	O
bilateral	O
ACE	O
bandages	O
wrapping	O
legs	O
Skin:	O
thin	O
skin	O
on	O
arms	O
bilaterally,	O
with	O
echymoses	O
diffusely	O
on	O
upper	O
arms	O
Neuro:	O
alert	O
and	O
interactive,	O
moves	O
all	O
extremities,	O
grossly	O
non-focal	O
At	O
discharge	O
General:	O
Alert,	O
in	O
no	O
acute	O
distress,	O
sitting	O
up,	O
pleasant	O
and	O
interactive	O
Tele:	O
atrial	O
fibrillation,	O
VRs	O
___	O
mainly	O
but	O
130s	O
briefly	O
with	O
ambulation	O
VS:	O
T	O
97.5	O
BP	O
118/75	O
Pulse	O
87	O
RR	O
18	O
SaO2	O
96%	O
on	O
RA	O
Weight:	O
72.0	O
k	O
HEENT:	O
Sclera	O
anicteric,	O
neck	O
supple,	O
JVP	O
not	O
appreciable	O
CV:	O
irregularly	O
irregular,	O
___	O
harsh	O
systolic	O
murmur	O
at	O
RUSB	O
Lungs:	O
Clear	O
to	O
auscultation	O
bilaterally--no	O
wheezes,	O
rales,	O
rhonchi	O
Abdomen:	O
Soft,	O
non-tender,	O
non-distended	O
GU:	O
no	O
Foley	O
Ext:	O
lower	O
extremities	O
edematous	O
with	O
skin	O
thickening,	O
edema	O
largely	O
non-pitting,	O
with	O
chronic	O
lymphedema	O
improved	O
since	O
admission	O
Skin:	O
thinning	O
skin	O
arms	O
bilaterally	O
with	O
echymoses	O
Neuro:	O
alert	O
and	O
interactive,	O
moving	O
all	O
extremities,	O
grossly	O
non-focal	O
Pertinent	O
Results:	O
___	O
04:30PM	O
BLOOD	O
WBC-6.8	O
RBC-3.99	O
Hgb-13.2	O
Hct-41.0	O
MCV-103*	O
MCH-33.1*	O
MCHC-32.2	O
RDW-14.0	O
RDWSD-53.3*	O
Plt	O
___	O
___	O
04:30PM	O
BLOOD	O
Neuts-63.3	O
___	O
Monos-8.9	O
Eos-1.2	O
Baso-0.7	O
Im	O
___	O
AbsNeut-4.33	O
AbsLymp-1.75	O
AbsMono-0.61	O
AbsEos-0.08	O
AbsBaso-0.05	O
___	O
04:30PM	O
BLOOD	O
___	O
PTT-32.9	O
___	O
___	O
04:30PM	O
BLOOD	O
Glucose-104*	O
UreaN-18	O
Creat-1.0	O
Na-140	O
K-4.7	O
Cl-104	O
HCO3-23	O
AnGap-18	O
___	O
05:25AM	O
BLOOD	O
ALT-38	O
AST-66*	O
AlkPhos-132*	O
TotBili-1.3	O
___	O
04:30PM	O
BLOOD	O
cTropnT-<0.01	O
proBNP-1255*	O
___	O
05:25AM	O
BLOOD	O
TSH-3.2	O
___	O
06:55AM	O
BLOOD	O
WBC-5.8	O
RBC-3.52*	O
Hgb-11.9	O
Hct-35.8	O
MCV-102*	O
MCH-33.8*	O
MCHC-33.2	O
RDW-14.1	O
RDWSD-52.5*	O
Plt	O
___	O
___	O
06:55AM	O
BLOOD	O
___	O
___	O
06:55AM	O
BLOOD	O
Glucose-84	O
UreaN-22*	O
Creat-1.0	O
Na-140	O
K-4.2	O
Cl-102	O
HCO3-27	O
AnGap-15	O
___	O
06:55AM	O
BLOOD	O
Calcium-8.7	O
Phos-3.6	O
Mg-2.1	O
ECG	O
___	O
2:04:44	O
___	O
Artifact	O
is	O
present.	O
Atrial	O
fibrillation	O
with	O
a	O
controlled	O
ventricular	O
response.	O
No	O
previous	O
tracing	O
available	O
for	O
comparison.	O
CXR	O
___	O
There	O
is	O
no	O
focal	O
consolidation,	O
effusion,	O
or	O
pneumothorax.	O
The	O
cardiac	O
silhouette	O
size	O
is	O
top	O
normal.	O
Aorta	O
is	O
tortuous	O
with	O
atherosclerotic	O
calcifications	O
noted	O
at	O
the	O
arch.	O
There	O
is	O
mild	O
S-shaped	O
curvature	O
to	O
the	O
thoracic	O
spine	B-Vertebral_compression_fracture
with	O
probable	O
compression	O
deformity	O
at	O
the	O
thoracolumbar	O
junction,	O
of	O
indeterminate	O
age.	O
There	O
is	O
no	O
fracture.	B-Vertebral_compression_fracture
No	O
free	O
air	O
below	O
the	O
right	O
hemidiaphragm	O
is	O
seen.	O
Echocardiogram	O
___	O
The	O
left	O
atrium	O
is	O
mildly	O
dilated.	O
The	O
right	O
atrium	O
is	O
moderately	O
dilated.	O
The	O
estimated	O
right	O
atrial	O
pressure	O
is	O
___	O
mmHg.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
(LVEF>55%).	O
There	O
is	O
considerable	O
beat-to-beat	O
variability	O
of	O
the	O
left	O
ventricular	O
ejection	O
fraction	O
due	O
to	O
an	O
irregular	O
rhythm/premature	O
beats.	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
severely	O
thickened/deformed.	O
The	O
aortic	O
valve	O
VTI	O
=	O
83	O
cm.	O
There	O
is	O
severe	O
aortic	O
valve	O
stenosis	O
(valve	O
area	O
<1.0cm2).	O
Mild	O
(1+)	O
aortic	O
regurgitation	O
is	O
seen.	O
[Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
aortic	O
regurgitation	O
may	O
be	O
significantly	O
UNDERestimated.]	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
An	O
eccentric,	O
posteriolry	O
directed	O
jet	O
of	O
moderate	O
to	O
severe	O
(3+)	O
mitral	O
regurgitation	O
is	O
seen.	O
[Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
mitral	O
regurgitation	O
may	O
be	O
significantly	O
UNDERestimated.]	O
Due	O
to	O
the	O
eccentric	O
nature	O
of	O
the	O
regurgitant	O
jet,	O
its	O
severity	O
may	O
be	O
significantly	O
underestimated	O
(Coanda	O
effect).	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
Severe	O
aortic	O
stenosis.	O
Mild	O
aortic	O
regurgitation.	O
Moderate	O
to	O
severe	O
mitral	O
regurgitation.	O
Preserved	O
biventricular	O
systolic	O
function.	O
Mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
Brief	O
Hospital	O
Course:	O
___	O
with	O
history	O
of	O
severe	O
AS	O
and	O
atrial	O
fibrillation	O
(on	O
metoprolol	O
and	O
warfarin)	O
admitted	O
with	O
several	O
weeks	O
of	O
progressive	O
bilateral	O
lower	O
extremity	O
edema	O
consistent	O
with	O
exacerbation	O
of	O
diastolic	O
heart	O
failure,	O
discharged	O
home	O
on	O
oral	O
diuretic	O
regimen	O
with	O
plan	O
to	O
follow	O
up	O
outpatient	O
for	O
___	O
work	O
up.	O
#	O
Aortic	O
Stenosis,	O
Severe,	O
Acute	O
on	O
Chronic	O
Diastolic	O
HF:	O
Patient	O
has	O
a	O
history	O
severe	O
aortic	O
stenosis	O
but	O
has	O
no	O
symptoms	O
of	O
presyncope/syncope,	O
dyspnea	O
at	O
rest	O
or	O
exertion,	O
or	O
chest	O
pain.	O
Patient	O
is	O
not	O
a	O
surgical	O
candidate	O
for	O
AVR.	O
Patient	O
and	O
daughter	O
spoke	O
to	O
___	O
team	O
and	O
would	O
like	O
to	O
pursue	O
further	O
workup	O
as	O
outpatient.	O
Given	O
response	O
to	O
diuresis	O
with	O
~4	O
kg	O
drop	B-Weight_loss
in	B-Weight_loss
body	B-Weight_loss
weight	B-Weight_loss
and	O
improvement	O
in	O
her	O
lower	O
extremity	O
edema	O
(superimposed	O
on	O
chronic	O
lymphedema),	O
the	O
patient	O
likely	O
has	O
diastolic	O
heart	O
failure.	O
She	O
was	O
discharged	O
on	O
torsemide	O
5	O
mg	O
PO	O
daily.	O
Given	O
limited	O
baseline	O
level	O
of	O
function,	O
physical	O
therapy	O
was	O
consulted	O
and	O
recommended	O
discharge	O
to	O
home	O
with	O
home	O
___	O
to	O
maximize	O
functional	O
mobility,	O
safety,	O
and	O
independence.	O
Daughter	O
at	O
bedside	O
prior	O
to	O
discharge	O
feels	O
ready	O
to	O
have	O
patient	O
safely	O
discharged	O
home	O
under	O
her	O
and	O
her	O
family's	O
care.	O
Patient	O
has	O
follow	O
up	O
with	O
Dr.	O
___	O
___	O
for	O
further	O
discussion)	O
and	O
is	O
to	O
follow	O
up	O
with	O
Dr.	O
___	O
(primary	O
cardiologist)	O
and	O
her	O
PCP	O
upon	O
discharge.	O
#	O
Atrial	O
Fibrillation:	O
Majority	O
of	O
hospitalization	O
with	O
good	O
rate	O
control,	O
although	O
ventricular	O
rates	O
up	O
to	O
130s	O
with	O
minimal	O
ambulation,	O
likely	O
secondary	O
to	O
deconditioning.	O
INR	O
therapeutic	O
on	O
admission.	O
Warfarin	O
continued	O
and	O
patient	O
discharged	O
on	O
metoprolol	O
succinate	O
100	O
mg	O
daily.	O
****TRANSITIONAL	O
ISSUES****	O
Discharge	O
Weight:	O
72	O
kg	O
New	O
medications:	O
Torsemide	O
5	O
mg	O
PO	O
DAILY,	O
metoprolol	O
succinate	O
100	O
mg	O
PO	O
DAILY	O
-	O
Has	O
appointment	O
with	O
Dr.	O
___	O
for	O
further	O
workup	O
for	O
aortic	O
stenosis	O
interventions	O
-	O
Patient	O
with	O
macrocytosis	O
on	O
CBC	O
on	O
labs.	O
TSH	O
wnl.	O
-	O
Patient	O
with	O
minor	O
LFT	O
abnormalities	O
on	O
admission,	O
no	O
abdominal	O
pain.	O
Deferred	O
for	O
outpatient	O
work	O
up.	O
-	O
Patient	O
with	O
thrombocytopenia	O
during	O
admission,	O
nadir	O
116	O
K	O
and	O
uptrending	O
prior	O
to	O
discharge.	O
-	O
Patient	O
to	O
have	O
labs	O
draw	O
on	O
___	O
BMP,	O
INR;	O
to	O
be	O
faxed	O
to	O
PCP	O
___	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
PO	O
TID	O
2.	O
Warfarin	O
4	O
mg	O
PO	O
DAILY16	O
3.	O
DiphenhydrAMINE	O
25	O
mg	O
PO	O
QHS	O
insomnia	O
Discharge	O
Medications:	O
1.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
DAILY	O
RX	O
*metoprolol	O
succinate	O
100	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
2.	O
Torsemide	O
5	O
mg	O
PO	O
DAILY	O
RX	O
*torsemide	O
5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
3.	O
DiphenhydrAMINE	O
25	O
mg	O
PO	O
QHS	O
insomnia	O
4.	O
Warfarin	O
4	O
mg	O
PO	O
DAILY16	O
5.	O
Outpatient	O
Lab	O
Work	O
BMP,	O
INR	O
on	O
___	O
ICD9Code:	O
___	O
PLEASE	O
FAX	O
TO	O
___	O
Fax	O
#:	O
___	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
-Acute	O
on	O
chronic	O
diastolic	O
Heart	O
Failure	O
-Severe	O
Aortic	O
Stenosis	O
-Persistent	O
atrial	O
fibrillation,	O
on	O
warfarin	O
-Chronic	O
bilateral	O
lymphedema	O
-Thrombocytopenia	O
-Abnormal	O
transaminases	O
-Macrocytosis	O
of	O
red	O
blood	O
cells	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
because	O
your	O
primary	O
care	O
doctor	O
was	O
concerned	O
about	O
your	O
leg	O
swelling.	O
Given	O
your	O
history	O
of	O
aortic	O
stenosis,	O
you	O
received	O
an	O
ultrasound	O
of	O
your	O
heart	O
to	O
determine	O
the	O
function	O
of	O
your	O
heart.	O
You	O
were	O
seen	O
by	O
the	O
cardiologists	O
and	O
surgeons	O
and	O
after	O
careful	O
discussion,	O
you	O
and	O
the	O
medical	O
team	O
decided	O
that	O
you	O
do	O
not	O
need	O
a	O
replacement	O
valve.	O
You	O
are	O
not	O
feeling	O
symptoms	O
of	O
your	O
valve,	O
which	O
is	O
good.	O
Please	O
follow	O
up	O
with	O
your	O
primary	O
care	O
doctor,	O
___,	O
___	O
and	O
your	O
cardiologist,	O
Dr.	O
___.	O
We	O
made	O
an	O
appointment	O
with	O
Dr.	O
___	O
can	O
further	O
assess	O
possibilities	O
of	O
intervention	O
with	O
your	O
valve	O
if	O
you	O
chose	O
to	O
do	O
so.	O
Please	O
get	O
your	O
labs	O
checked	O
on	O
___	O
outpatient	O
to	O
check	O
your	O
INR	O
and	O
electrolyte	O
panel.	O
Please	O
weight	O
yourself	O
daily	O
on	O
a	O
good	O
quality	O
scale	O
after	O
urinating	O
in	O
the	O
morning	O
in	O
light	O
weight	O
clothing.	O
___	O
call	O
MD	O
if	O
weight	O
increases	O
by	O
more	O
than	O
3lbs	O
in	O
one	O
day	O
or	O
5lbs	O
in	O
one	O
week	O
We	O
wish	O
you	O
the	O
best,	O
Your	O
___	O
Care	O
team	O
Followup	O
Instructions:	O
___	O

